Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa
| dc.contributor.author | Horna, Gertrudis | |
| dc.contributor.author | López, María | |
| dc.contributor.author | Guerra, Humberto | |
| dc.contributor.author | Sáenz, Yolanda | |
| dc.contributor.author | Ruiz, Joaquim | |
| dc.date.accessioned | 2019-06-05T14:11:50Z | |
| dc.date.available | 2019-06-05T14:11:50Z | |
| dc.date.issued | 2018-11-07 | |
| dc.date.updated | 2019-05-27T08:59:38Z | |
| dc.description.abstract | MexAB-OprM and MexEF-OprN are Pseudomonas aeruginosa efflux pumps involved in the development of antibiotic resistance. Several studies developed with laboratory strains or using a few clinical isolates have reported that the regulation system of MexEF-OprN is involved in the final levels of MexAB-OprM expression. Therefore, this study was aimed to determine the interplay between MexAB-OprM and MexEF-OprN in 90 out of 190 P. aeruginosa clinical isolates with an efflux pump overexpression phenotype. Regarding oprD, 33% (30/90) of isolates displayed relevant modifications (RM) defined as frameshift or premature stop, both related to carbapenem resistance. On the other hand, 33% of the isolates displayed RM in nalC, nalD or mexR, which were significantly associated with multidrug resistance (MDR), non-susceptibility to carbapenems, OprD alterations and strong biofilm production. Meanwhile, the RM in MexS were associated with presence of pigment (p = 0.004). Otherwise, when all the regulators were analysed together, the association between RM in MexAB-OprM regulators and MDR was only significant (p = 0.039) when mexS was the wild type. These data show the modulatory effect of MexEF-OprN on MexAB-OprM in a clinical population of P. aeruginosa. Further studies may contribute to design of novel molecules acting on this interplay to fight against antimicrobial resistance. | |
| dc.format.extent | 11 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.issn | 2045-2322 | |
| dc.identifier.pmid | 30405166 | |
| dc.identifier.uri | https://hdl.handle.net/2445/134579 | |
| dc.language.iso | eng | |
| dc.publisher | Nature Publishing Group | |
| dc.relation.isformatof | Reproducció del document publicat a: http://dx.doi.org/10.1038/s41598-018-34694-z | |
| dc.relation.ispartof | Scientific Reports, 2018, vol. 8 | |
| dc.relation.uri | http://dx.doi.org/10.1038/s41598-018-34694-z | |
| dc.rights | cc by (c) Horna et al., 2018 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | |
| dc.source | Articles publicats en revistes (ISGlobal) | |
| dc.subject.classification | Pseudomonas | |
| dc.subject.classification | Resistència als medicaments | |
| dc.subject.other | Drug resistance | |
| dc.title | Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1
Carregant...
- Nom:
- Horna_G_Sci_Rep_2018.pdf
- Mida:
- 1.53 MB
- Format:
- Adobe Portable Document Format